Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 236
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Former Compass Interim Clinical Sciences Director Joins Clerkenwell Health as CMO
MINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental...
Awakn Life Sciences Reports Second Quarter 2021 Financial Results and Business...
Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation...
Understanding ‘Spiritual Emergency’ in the Context of Psychedelics
atai Life Sciences Increases Loan in Principal by US$6m to Support...
Small Pharma Announces Engagement of Investor Relations Provider
Fear of Death Impacts Quality of Life-How Psychedelics Can Help
PT262 – Carlene MacMillan, M.D. – Set, Setting, and Systems: Adding...
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment...
Load more